We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+19.51%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$329M
AUM Growth
+$45.4M
Cap. Flow
-$5.16M
Cap. Flow %
-1.57%
Top 10 Hldgs %
60.33%
Holding
98
New
11
Increased
26
Reduced
33
Closed
8

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$2.23M
2
AVGO icon
Broadcom
AVGO
+$1.13M
3
KEYS icon
Keysight
KEYS
+$1.09M
4
CSCO icon
Cisco
CSCO
+$1.07M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1M

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$3.57M
2
CELG
Celgene Corp
CELG
+$3.2M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.86M
4
GILD icon
Gilead Sciences
GILD
+$1.26M
5
AAPL icon
Apple
AAPL
+$880K

Sector Composition

Rank Sector Weight
1 Healthcare 37.15%
2 Industrials 17.26%
3 Energy 13.8%
4 Technology 11.85%
5 Financials 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
Merck
MRK
$322B
$55.8M 16.96%
703,218
-10,480
-1% -$784K
UNP icon
2
Union Pacific
UNP
$181B
$25.9M 7.87%
155,000
-5,000
-3% -$805K
XOM icon
3
ExxonMobil
XOM
$650B
$25M 7.61%
309,996
-11,100
-3% -$846K
ROP icon
4
Roper Technologies
ROP
$35.8B
$15.6M 4.75%
45,672
-70
-0.2% -$21.3K
TMO icon
5
Thermo Fisher Scientific
TMO
$213B
$15.3M 4.64%
55,758
-136
-0.2% -$33.8K
MUR icon
6
Murphy Oil
MUR
$5.65B
$14.9M 4.52%
507,855
– –
CELG
7
DELISTED
Celgene Corp
CELG
$13.2M 4.01%
139,781
-36,608
-21% -$3.2M
AME icon
8
Ametek
AME
$55.3B
$12.2M 3.7%
146,852
-473
-0.3% -$35.9K
JPM icon
9
JPMorgan Chase
JPM
$930B
$11.3M 3.44%
111,691
+1,129
+1% +$116K
MSFT icon
10
Microsoft
MSFT
$2.83T
$9.35M 2.84%
79,252
-760
-0.9% -$82.9K
AMT icon
11
American Tower
AMT
$76.7B
$7.88M 2.4%
40,000
– –
TECH icon
12
Bio-Techne
TECH
$11.2B
$6.06M 1.84%
122,028
+5,320
+5% +$239K
PCH
13
DELISTED
PotlatchDeltic
PCH
$5.73M 1.74%
151,661
– –
PH icon
14
Parker-Hannifin
PH
$124B
$5.67M 1.72%
33,013
-2,296
-7% -$381K
COO icon
15
Cooper Companies
COO
$13.7B
$4.74M 1.44%
64,000
– –
GPN icon
16
Global Payments
GPN
$21.3B
$4.04M 1.23%
29,555
-8
-0% -$971
AMZN icon
17
Amazon
AMZN
$2.51T
$3.96M 1.2%
44,480
+10,180
+30% +$847K
MUSA icon
18
Murphy USA
MUSA
$11.5B
$3.72M 1.13%
43,413
– –
IDXX icon
19
Idexx Laboratories
IDXX
$42.5B
$3.71M 1.13%
16,585
+2,998
+22% +$619K
AAPL icon
20
Apple
AAPL
$4.72T
$3.64M 1.11%
76,588
-20,748
-21% -$880K
BA icon
21
Boeing
BA
$165B
$3.62M 1.1%
9,496
-9,280
-49% -$3.57M
GOOGL icon
22
Alphabet (Google) Class A
GOOGL
$3.88T
$3.11M 0.95%
52,900
-1,160
-2% -$65.5K
GH icon
23
Guardant Health
GH
$19.9B
$3.08M 0.94%
+40,155
New +$2.23M
GILD icon
24
Gilead Sciences
GILD
$162B
$2.81M 0.85%
43,200
-19,000
-31% -$1.26M
EOG icon
25
EOG Resources
EOG
$77.5B
$2.74M 0.83%
28,790
-21
-0.1% -$2K
1
2 3 4

Similar funds

SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Aristotle Atlantic Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Aristotle Atlantic Partners held 98 positions worth $329M, up 16% from $284M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Aristotle Atlantic Partners's Q1 2019 filing shows 11 new, 26 increased, 33 reduced and 8 closed positions. Its largest new stake was Guardant Health: 40,155 shares worth $3.08M. The largest sale was Boeing, an estimated $3.57M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 37% a quarter earlier, followed by Industrials and Energy.

  • Aristotle Atlantic Partners's largest Q1 2019 buy was Guardant Health: 40,155 shares worth $3.08M.
  • Aristotle Atlantic Partners added most to Supernus Pharmaceuticals in Q1 2019, an estimated $1M increase.
  • Aristotle Atlantic Partners's biggest Q1 2019 reduction was Boeing, cutting an estimated $3.57M.
  • Aristotle Atlantic Partners fully exited State Street SPDR S&P 500 ETF Trust in Q1 2019, selling an estimated $1.86M.
  • Aristotle Atlantic Partners's ten largest holdings make up 60% of its $329M portfolio in Q1 2019.
  • Aristotle Atlantic Partners opened 11 new positions and closed 8 in Q1 2019.
  • Aristotle Atlantic Partners's portfolio value rose 16% quarter-over-quarter to $329M.

Based on Aristotle Atlantic Partners's 13F filing for Q1 2019, filed 15 May 2019.